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Paracrine signalingSensing systems based on Förster resonance energy transfer (FRET) can be used to monitor enzymatic
reactions, protein–protein interactions, changes in conformation, and Ca2+ oscillations in studies on cellular
dynamics. We developed a series of FRET-based chimeric bioprobes, each consisting of ﬂuorescent protein
attached to a ﬂuorescent dye. Green and red ﬂuorescent proteins were used as donors and a series of Alexa
Fluor dyes was used as acceptors. The basic ﬂuorescent proteins were substituted with appropriate amino
acids for recognition of the target (caspase-3) and subjected to site-directed modiﬁcation with a ﬂuorescent
dye. Variants that retained similar emission proﬁles to the parent proteins were readily derived for use as
FRET-based bioprobes with various ﬂuorescent patterns by incorporating various ﬂuorescent proteins and
dyes, the nature of which could be adjusted to experimental requirements. All the constructs prepared
functioned as bioprobes for quantitative measurement of caspase-3 activity in vitro. Introduction of the
bioprobes into cells was so simple and efﬁcient that activation of caspase-3 upon apoptosis could be
monitored bymeans of cytometric analysis. FRET-based bioprobes are valuable tool for high-throughput ﬂow-
cytometric analysis of many cellular events when used in conjunction with other ﬂuorescent labels or
markers. Statistical dynamic studies on living cells could provide indications of paracrine signaling.red ﬂuorescent protein; FACS,
ifetime imaging; FRET, Förster
ein; Qdot, quantum dot; PBS,
55 Shimo-okubo, Sakura-ku,
ki).
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High-throughput cell analysis by using ﬂow cytometry is gaining in
importance as a technique for quantiﬁcation of cellular events and for
drug screening. The technique has also been extended to permit
discrimination of various labeled molecules. In many cases, however,
labeling of biological substances can have similar effects to staining and
can result in cell ﬁxation, so that it might only be possible to visualize
static states within cells [1]. Fluorescence-activated cell sorting (FACS),
the most popular application of ﬂow cytometry, requires damage-free
staining or labeling of cells to permit further processing after the initial
sort. Förster resonance energy transfer (FRET)-based sensing might be
capable of supplying more-dynamic information regarding biologicalprocesses [2,3] in comparison with standard ﬂuorescent staining or
labeling, but a robust pair of ﬂuorescent molecules (a donor and an
acceptor) is required. Fluorescence-lifetime imaging (FLIM), which is
based on related principles, has also been developed for imaging of
living cells [4]. In practice, however, FRET- or FLIM-supported high-
throughput approaches are rather difﬁcult to achieve in practice [5–7].
Matching of elaborate tools for FRET or FLIM with a simple mass-
processing system, such as ﬂow cytometry, might also be problematic.
We designed simple but robust combinatorial FRET pairs to permit
the adaptation of widely used ﬂow cytometry systems for use in
statistical analyses of living cells.We generated a bioprobe consisting of
a f luorescent protein as a donor and a dye as an acceptor with three
unique features: (i) the donor can be readily reconstructed by gene
manipulations for a variety of objective phenomenonwhile retaining its
f luorescent properties; (ii) the FRET pair can be replaced by other
f luorescent proteins or dyes to alter the emission profiles to suite the
experimental conditions while remaining active for the original object;
and (iii) the chimeric compound can be introduced efficiently into cells.
We previously engineered green f luorescent protein (GFP) to
permit thiol-reactive modiﬁcation to introduce a new cysteine (Cys)
group at a surface position suitable for site-specific attachment of a
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a ﬂuorescent tag [10]. The modiﬁed products showed excellent chemical
FRETwhenused in conjunctionwith theGFP chromophore.Mutant forms
of GFP containing additional protease-recognition sequences near the
dye-bearing Cys group functioned as bioprobes for proteolysis in
microscopic imaging of living cells when they were introduced into cells
bymeans of a protein-delivery reagent [11]. In a similarmanner, we have
constructed various bioprobes that are sensitive to reducing agents [12],
DNase, kinase, or thepHof themedium(unpublisheddata). In thepresent
report,wedescribe our attempts at systematic expansion of combinations
of fluorescent proteins and dyes to target caspase-3 as an important
indicator of cell death. By means of cytometric analysis, we checked the
performance of the bioprobes inside cells as well the efficiency of their
delivery into cells.
Consequently,wedemonstrated that compatible pairs of f luorescent
proteins and dyes can function as quantitative caspase-3 sensors in
vitro, and that the bioprobe-containing cells permit the detection of
protease activities upon induction of apoptosis. We believe that our
bioprobes will be highly suitable for use in ﬂow cytometry because of
their tunable emission proﬁles when used in conjunction with other
markers, such as functional ﬂuorescent reagents or phycoerythrin
tandem dyes, and because they permit an extensive range of laser or
ﬁlter options. Moreover, studies onmass reactions to various apoptosis-
triggering reagents suggested that there could bedifferences in the rates
of acceleration of apoptotic events, but not in the activation levels of
caspase-3, in cases where such responses appeared to be regulated by
paracrine-like intercell communication.
2. Materials and methods
2.1. Plasmid construction for the f luorescent protein
Plasmid pQE81-DsRed T3 (kindly provided by Dr B. S. Glick of the
University of Chicago, Chicago, IL, USA) [13] was reconstructed into a
gene encoding a redﬂuorescentprotein (RFP)-basedbioprobebymeans
of a triple, sequential, inverse polymerase chain reaction (PCR) [14]. The
first manipulation was performed to replace the native Cys residue
located at the 117 position of RFP with a glutamate (Glu) residue. The
secondmanipulation involved elongation of theC-terminalwithGTCGG
HHHHHH amino acid sequences for site-specific chemical modiﬁcation
and protein puriﬁcation. The ﬁnal manipulation was to insert the SGT
DEVD amino acid sequences (which are susceptible sequences of
caspase-3 [15]) between the original C-terminal and the extended
GTCGG HHHHHH sequences described above. We thus obtained a
plasmid-harboring gene for use as an RFP-based caspase-3-sensitive
bioprobe,whichwe named pT3castag. The previously prepared plasmid
pUV5casS52tag [11] was used as a GFP-based bioprobe for caspase-3.
2.2. Protein isolation
The two types of plasmid described above (pUV5casS52tag and
pT3castag) were transferred into Escherichia coli BL-21(DE3) (Merck
Biosciences, Darmstadt, Germany). Each bacterium obtained from a
single colony was grown at 37 °C in lysogeny broth (LB) medium
containing 75 μg/ml ampicillin for 12 h. An aliquot of the culture
medium was diluted into ten times its volume of fresh LB medium
supplementedwith 75 μg/ml ampicillin, and cultured at 28 °C for 48 h.
The bacteria were harvested and lysed with an adequate amount of
bacterial protein extraction reagent B-PER II (Thermo Fisher Scientific
Inc., Waltham, MA, USA). Lysates were separated into a supernatant
and cell debris by centrifugation at 15,000 rpm for 15 min at room
temperature. The supernatant was applied to a Ni2+-NTA resin
(Qiagen, Düsseldorf, Germany) according to a standard procedure for
the purification of histidine tag-fused proteins. The protein recovered
from the resin treatments was reconstituted in phosphate-buffered
saline (PBS) and checked for purity and oligomerization by means ofsodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS–
PAGE), and quantified and qualified by measurement of the
absorbances at 280 nm and 488 nm for the GFP variant or 280 nm
and 565 nm for the RFP variant, respectively. Fluorescent proteins for
use in GFP-based (UV5casS52tag) and RFP-based (T3castag) moieties
were thus prepared.
2.3. Protein modification with f luorescent dye
The purified f luorescent proteins were chemically modified with
various ﬂuorescent dyes (all from Life Technologies Corp., Carlsbad,
CA, USA). The protein was dissolved in PBS (10 μl) containing 1 mM of
dithiothreitol (DTT) to give a 10-μM solution that was incubated for
10 min at room temperature. DTT was removed by gel ﬁltration (NICK
column, GE Healthcare UK Ltd., Chalfont St Giles, UK). An aliquot of
the eluate (400 μl) was immediately mixed with 2 μl of a 2 mg/ml
solution of the f luorescent dye in dimethyl sulfoxide (DMSO), and the
mixture was incubated at 37 °C for 4 h. Excess dye was removed on a
NICK Column equilibrated with PBS. The ﬂuorescence spectrum was
measured at an excitationwavelength of 488 nm (for GFP derivatives)
or 565 nm (for RFP derivatives) by using a Shimadzu RF-5300PC
spectrof luorophotometer (Shimadzu, Kyoto, Japan). Because the FRET
efficiency is defined as the ratio of the donor ﬂuorescence intensities
in the presence of an acceptor molecule to that in the absence such a
molecule, and not as the ratio of the donor and acceptor f luorescent
intensities [16], we compared the emission proﬁles in terms of the
FRET efficiency for each bioprobe quantitatively by using the same
amount of ﬂuorescent protein in each case to show the extents of
donor quenching in arbitrary units (a.u.).
2.4. Bioprobe digestion with caspase-3
The chemically derivatized ﬂuorescent proteins UV5casS52tag or
T3castag (100 μl of a 40 μM soln) joined to various Alexa Fluor dyes
were passed through an ultracentrifugal ﬁlter column (Microcon
YM-10; Millipore Corp., Billerica, MA, USA) to adjust the bioprobe
concentration. Caspase-3 (2 units) (MBL Co. Ltd., Nagoya, Japan) was
added to a 5-μM aliquot of the bioprobe solution reconstituted in
caspase assay buffer containing 20 mM 2-[4-(2-sulfoethyl)
piperazin-1-ium-1-yl]ethanesulfonate (PIPES), 100 mM NaCl, 0.1%
3-[dimethyl(3-{[(3α,5β,7α,12α)-3,7,12-trihydroxy-24-oxocholan-
24-yl]amino}propyl)ammonio]propane-1-sulfonate (CHAPS), 10 mM
DTT, 10% sucrose, and 1 mM EDTA. The mixture was then incubated
for 2 h at 30 °C. We also prepared a similar sample without caspase-3
as a control. Fluorescence spectra for all the samples were measured
in a similar manner to that used to deduce the FRET efﬁciencies (see
Section 2.3), and a pair of emission proﬁles was obtained for each
bioprobe.
2.5. Introduction of the bioprobe into cells
The dye–f luorescent protein conjugate (~100 μg) dissolved in 100 μl
of PBSwas added to a tube coveredwith a dryﬁlmof BioPORTER reagent
(Genlantis, SanDiego, CA,USA). Themixturewas left to stand for 10 min
at room temperature to permit formation of BioPORTER/protein
complexes. The resulting suspension was dispersed in 900 μl of
serum-free culture medium [Dulbecco's modiﬁed Eagle's medium
(DMEM) for HeLa cells or RPMI1640 for Jurkat cells; Invitrogen Corp.,
Carlsbad, CA, USA]. The suspensionwas added directly to adherentHeLa
cells cultured in a 35-mm dish or to collected Jurkat cells (2×105 to
4×105) in a culture tube. After incubation for 3 h at 37 °C in an
atmosphere containing 5% CO2, the culture medium containing the
remaining BioPORTER/protein complexes was removed and washed
with an appropriate medium for ﬂow cytometry analysis. The
dependence of the intake of the bioprobe into the cells on its
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BioPORTER/protein complex.
2.6. Flow cytometry analysis
Bioprobe-containing HeLa cells in a 35-mm dish were washed
with PBS (2×1 ml) then treated with 0.25% trypsin solution (1 ml)
and left to stand at 37 °C to permit detachment from the dish. The cell
suspension was collected in a 1.5-ml centrifuge tube and centrifuged
at 1000 rpm for 10 min. The cell pellet was resuspended in 1 ml of
DMEMwithout serum or phenol red. These steps were repeated once.
The ﬁnal cell suspension was analyzed by using a FACSAria f low
cytometer (Becton–Dickinson Bioscience, San Jose, CA, USA) with
excitation by a blue laser at 488 nm. The cell f luorescence was
measured over the FL-1, FL-2, and FL-3 channels.
The bioprobe-containing Jurkat cells were similarly collected in a
1.5-ml tube by centrifugation at 1000 rpmfor 10 min. The cell pelletwas
washed twice with RPMI 1640 without serum by repeated centrifuga-
tion. The resulting cells were resuspended in 3 ml of the samemedium
and subjected to cytometric analysis. In the case of the apoptotic-
induction experiments, the Jurkat cells were incubated under an
atmosphere containing 5% CO2 for 2 h at 37 °C in a culture medium
containing 40 ng/ml of TNF-α and 100 μg/ml of cycloheximide (CHX) or
in a medium containing 5 μM of camptothecin (CPT) (Merck Bio-
sciences, Darmstadt, Germany) [17]. The apoptosis-triggering reagents
were removed by a similar procedure to that used to wash out the
bioprobe. Cells not treated with the reagent were also subjected to an
identical washing procedure before f low cytometry.
2.7. Staining with annexin V and propidium iodide
Aliquots of Jurkat cells optionally treatedwith 5 μMof camptothecin
were washed twice with ice-cold PBS. They were then resuspended in0
50
100
150
200
250
500 550 600 650 700
Wavelength (nm)
Fl
uo
re
sc
en
ce
 In
te
ns
ity
 (a
.u.
)
A  
B
FP
Protease
FRET
Dye
Fig. 1. Functional basis of the bioprobe. (A) Schematic representation of mechanism for sens
protease-digestible sequence near a site bearing a ﬂuorescent dye functions as a bioprobe fo
protein and dye. Emission patterns were examined after site-speciﬁc modiﬁcation of ﬂuoresc
(B) Green ﬂuorescent protein (GFP) attached to Alexa 532 moiety (red), Alexa 546 (green)
protein (RFP) attached to Alexa 633 (red), Alexa 647 (green), Alexa 660 (blue), or Alexa 681× Binding buffer containing a f luorescein 5-isothiocyanate [FITC;
2-(3,6-dihydroxy-9H-xanthen-9-yl)-5-isothiocyanatobenzoic acid]-
based Annexin V Apoptosis Detection Kit (BD Biosciences), according
to the manufacturer's instructions. The cell suspension (100 μL) was
transferred into a 5-ml culture tube and gently mixed with 5 μl of
annexin V solution and 2 μl of the propidium iodide solution, as
provided in the kit. Themixture was then incubated for 15 min at room
temperature in darkness. 1× Binding buffer (400 μL)was added and the
resulting solution was analyzed by ﬂow cytometry [18,19].
3. Results and discussion
3.1. Functional mechanism of the bioprobes and characterization of their
f luorescence properties
One objective of the present study was to conﬁrm the compati-
bility of various combinations of ﬂuorescent proteins and dyes as FRET
partners on sensor molecules for use as combinatorial bioprobes. We
initially chose a bioprobe targeting the protease caspase-3, because
the sensing mechanism for proteolysis by a FRET system (Fig. 1A)
should be simple and, because caspase-3 is a biologically significant
protease that participates in apoptosis, it is an important target of
several anticancer drugs. We then selected ﬂuorescent dyes for the
acceptor portion of the construct; the dyes that we used were a series
of commercially available Alexa dyes that were suitable as reagents
and had sequential variations in their excitation and emission spectra.
Our aim was to identify well-organized pair candidates. Next, we
designed a ﬂuorescent protein as the donor portion for use in addition
to the well-established GFP. We used Discosoma red f luorescent
protein (DsRed), which has a red-shifted emission maximum at
583 nm and a quite different emission proﬁle from that of GFP.
Crystallographic studies have shown that RFP forms a stable tetramer
inwhich eachmonomer unit has a very similar structure to that of GFP0
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been subjected to intensive improvements by means of gene
manipulation [22]. The main focus of these alterations has been on0
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permits insertion, deletion, or substitution. We therefore recon-
structed T3, which is a tetrameric, very bright, variant of RFP [13], for
use as the protein portion of our bioprobe construct.
We used Alexa-532, -546, -555, and -594 dyes for our GFP-based
bioprobes, and Alexa-633, -647, -660, and -680 dyes for our RFP-based
bioprobes. We checked the f luorescence patterns produced on
attachment of the dye to the f luorescent proteins to evaluate the
FRET efficiencies of the corresponding bioprobe and to verify our
assumptions regarding FRET-based sensing with a constant amount of
donor protein [8,9,16]. Considerable levels of donor quenching and
acceptor emission were observed for each combination (Fig. 1B and
C). We regarded our bioprobes as molecules that have equal FRET
potentials. Generally, the emission proﬁles of FRET-based sensing
molecules can be determined from the spectral overlap between the
emission from the donor and the absorption by the acceptor, in
conjunction with the extinction coefficients of the acceptor molecule
and other common parameters for FRET, as discussed in Section 2.3. It
might therefore be a characteristic of these probes to show
approximately constant FRET efficiencies despite differences in the
FRET parameters and the presence of f luctuations in the modification
competencies of the dye.
We then calculated the Förster radius (R0) for the f luorescent
protein–dyepairs by assumingκ2 values of 0.22, aspreviously calculated
by simulations [9], andwecompared the resulting valueof R0with other
estimations made by using a κ2 value of 2/3, as usually applied to
unrestrained labeling by ﬂuorescent dye (Supplementary Table 1). The
minimum value of κ2 was 0.22, calculated on the assumption that we
might use eosin as a modiﬁcation dye targeted at the C-terminal region
of the GFP variant. If other dyes were incorporated into the protein, the
corresponding κ2 values could be estimated from that of the dye-
modiﬁcation site of GFP or RFP; the value should be improved by
attachment of another dye at a different position on the protein. A value
of 2/3, on the other hand, is frequently used for dyes attached to a
biopolymer through linker structures. The other variables used in thecalculation were n−4=0.32 and donor QD=0.68 for GFP and 0.59 for
RFP. Although we introduced a disadvantageous κ2 value for the
calculation, the R0 values for Alexa-532, -546, -555, and -594 in GFP-
based bioprobes are 7 to 10 nmand those for Alexa-633, -647, -660, and
-680 in RFP-based bioprobes are in excess of 10 nm.
Moreover, we demonstrated that the calculated results of various
combinations fell within the visible region, showing that they were
suitable for use as bioprobes.
These R0 values should allow all bioprobes to show high
efﬁciencies in FRET, because we overestimated the distances between
the ﬂuorescent proteins and dyes to be 2–3 nm [8]. Although the site
that we used in the present study should give a low κ2 value, the
overall evaluation suggested that it is nevertheless a favorable
position for binding of an acceptor molecule for efﬁcient FRET [9]. In
dissimilar cases, it is possible to observe donor quenching and
acceptor emissions by mechanisms other than FRET. Molecular-
dynamics studies of GFP and dye complexes, however, suggested an
absence of direct interactions between the dye and the ﬂuorescent
protein chromophore. We also observed a marked reduction in the
lifetime of the donor ﬂuorescent proteins after modiﬁcation with the
dye, as shown in Supplementary Table 1, and we therefore confirmed
that the main cause of donor quenching and acceptor emissions is
likely to be FRET (unpublished data). FRET efficiencies can be
calculated precisely by using the same amount of donor protein
before and after dye attachment, because the FRET efficiency is
formulated in terms of the ﬂuorescence intensities of the donor in the
presence and absence of the acceptor (donor quenching). Neverthe-
less, well-designed bioprobes require extreme changes in the
ﬂuorescence intensities of the donor and in the emission maxima of
the acceptor in the presence of a target biological process. We
therefore estimated the efficiency of the bioprobe in relation to
changes in the ratio of the ﬂuorescence intensities of the donor and
the acceptor at their emission maxima during the target event shown
in Section 3.2. On the basis of our deﬁnition of FRET [16] in Section 2.3,
however, this ratio provides only a rough measure of the FRET
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the accepter channel, acceptor spillover to the donor channel, and
direct acceptor excitation at 488 nm or 565 nm in the course of FRET
estimation, we found that these were insigniﬁcant except in the case
of Alexa-532 bound to GFP. In this case, the ratio of the measured
ﬂuorescence intensity of the donor to that of the acceptor at their
emission maxima appeared to be considerably underestimated in
comparison with the calibrated ratio for these effects. In high-
throughput cytometric analysis, however, the simple ratio should be aA:GFP-based
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the chimeric bioprobes.
3.2. Evaluation of compatibilities of bioprobes by caspase-3 digestion in vitro
The responsiveness of eight combinations of bioprobe to caspase-3
was examined by means of ﬂuorescence spectroscopy. Significant
changes in the emission proﬁles upon treatment with caspase-3 werelexa 555  
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Jurkat cells (C). We introduced eight bioprobes (unmodiﬁed GFP, GFP–Alexa 546, GFP–
680) independently into HeLa cells. Adequate amounts of individual bioprobes were
ated for 4 h. Cells were collected by trypsinization and subjected to ﬂow cytometry. Cell
ssing of donor and acceptor emissions [ﬁve dot panels in (A) and (B)]. Gating for
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)] were plotted as functions of the emission ratio to show the cytometric proﬁles due to
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cells, except that the cells were recovered by centrifugation. Dot-plot analysis of donor
ntaining cells (second panels from the left), and two different concentrations of the
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221M. Suzuki et al. / Biochimica et Biophysica Acta 1823 (2012) 215–226observed, and typical pattern changes were found (Fig. 2A and B). We
calculated the emission ratio (dye emission maximum/ﬂuorescent
protein emissionmaximum) in the presence and absence of caspase-3
(Fig. 2C), as described in Section 3.1. We then approximated changes
in the ratio of the emission ratio with caspase-3 to that of the emission
ratio without caspase-3 (Fig. 2D). Changes in this ratio in excess of a
value of 2 suggested the bioprobe should be sufﬁciently sensitive to
permit detection of proteolysis in vitro. All the GFP-based bioprobes
and three RFP-based bioprobesmet this criterion. Becausewe checked
by PAGE (data not shown) that the RFP complexes still formed
tetramers after completion of dye modiﬁcation, we predicted that, as
result of steric hindrance, they should show poorer performances as
bioprobes than do GFP complexes. Our results (Fig. 2D), however,
showed that the oligomeric quaternary structures still gave satisfac-
tory results. These may arise from an apparent increase in substrate
concentrations rather than from the inaccessibility of the C-terminal
region of the ﬂuorescent proteins to caspase-3 in the cases of at least
three of the RFP complexes. We observed there was no unfavorabledigestion upon treatment with caspase-3 either (data not shown).
Therefore any sensitivities toward caspase-3 that were present among
the same ﬂuorescent protein-based bioprobes might have resulted
principally from dye-dependent differences in afﬁnity with the
catalytic center of caspase-3.
3.3. Detection of caspase-3 activity in a concentration-dependent
manner in vitro
Because it would be advantageous if FRET-based bioprobes could be
used inmonitoring dynamic biological phenomena,we further assessed
the properties of the bioprobe in sensing the activity of caspase-3 as a
function of concentration. We prepared and incubated assay buffers,
prepared as described in Section 2.4, containing various amount of
caspase-3 and a constant amount of GFP–Alexa 546 or RFP–Alexa 647,
andwemeasured the changes in the emission ratio (Fig. 2E and F). Each
experiment was repeated three times independently. The signiﬁcant
responses to the concentration of caspase-3 and the small divergences
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222 M. Suzuki et al. / Biochimica et Biophysica Acta 1823 (2012) 215–226betweenmeasurements showed that each of the bioprobes can be used
in quantitative detection of caspase-3 activities. Similarly, we examined
the time course of the caspase-3 reaction under equivalent conditions,
butwith themidpoint amount of caspase-3 shown in Fig. 2E or F. During
6 h of observation, the emission ratios changed continuously in a time-
proportional manner (data not shown). These results suggest that our
bioprobes might be capable of detecting dynamic reactions of the
enzyme.
3.4. Flow cytometry of bioprobe-containing HeLa and Jurkat cells
We assessed the efﬁciencies for the uptake of the bioprobes and of
plain ﬂuorescent proteins (GFP and RFP) in HeLa cells by using a
protein-transfection reagent. We measured the emission proﬁles of
the bioprobes and ﬂuorescent proteins inside the cells, and we
compared the results with those for cell population without any
protein delivery. To simplify the ﬂow cytometry system, we used only
a 488-nm blue laser for donor excitation. By gating of autoﬂuorescent
cell population, we conﬁrmed that around 90% of cells retained a
signiﬁcant amount of the ﬂuorescent protein or complex (Fig. 3A and
B; dot plot panels). The dot plot of cell distributions in reference to the
donor and acceptor emission intensities was mutually related to the
ﬂuorescent patterns obtained from in vitro measurements. That is, the
rates of donor quenching and acceptor emission shown in Fig. 2A
were mirrored in the slope of the dot spreads. We also processed dot-
plot cell data (Fig. 3A and B; histograms) as a function of the emission
ratio, as deﬁned previously in Section 3.2. The peak positions
attributed to the bioprobes were clearly different from those of the
simple ﬂuorescent proteins. We hypothesized that population
changes upon FRET cancelation by the action of proteases should be
detectable in most bioprobes, rendering choice of bioprobes emitting
non-overlapped f luorescence with other f luorescent labels adjustedon the subject of intensity in the future study. Furthermore, we
examined the dose-dependent delivery of bioprobes into Jurkat cells
(Fig. 3C). Because we detected saturations in the ﬂuorescent intensity
in the previous experiments with HeLa cells, we used a quarter of the
amount of the bioprobe in conjunction with the protein-transfection
reagent.We evaluated the distribution properties of unprocessed cells
as a control, together with those of cells transfected with plain donor
proteins and cells transfected with bioprobes. By eliminating auto-
ﬂuorescent cells from the analysis, we observed that plain ﬂuorescent
protein was less efﬁciently taken up by Jurkat cells than by HeLa cells.
Population centers of cells containing GFP–Alexa 546 or RFP–Alexa
647 were also positioned at low ﬂuorescent intensities, but at an
appropriate level with regard to the dose experiments shown in
Fig. 3A and B. When one quarter of the amount of bioprobe was used,
the cell distributions shifted to much lower intensities. These
experiments showed that we have some control over the amounts
of bioprobes delivered into cells. It will be essential to optimize the
uptake of bioprobes in relation to the sensitivities of the target and the
other conditions for the analysis.
3.5. Induction of apoptosis of bioprobe-containing Jurkat cells
Next, because caspase-3 is a well-known execution protease of
apoptosis [17], we used ﬂow cytometry to investigate the performance
of bioprobes as caspase-3 sensors inside Jurkat cells subjected to
apoptosis. First, we prepared nonprocessed Jurkat cells and GFP–Alexa
555- and RFP–Alexa 647-containing Jurkat cells, and we divided each
groupof cells into three for further treatmentwith (i) no reagent, (ii) the
apoptosis-triggering reagents TNF-α plus CHX, or (iii) and the
apoptosis-triggering reagent CPT, respectively. The donor and acceptor
emission intensities of nonprocessed cells were measured under three
sets of experimental conditions (the three sets ofﬁgures in the first rows
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Fig. 4.Monitoring of caspase-3 activities upon apoptotic induction in Jurkat cells to validate bioprobe function by cytometric analysis. (A) Cells were incubated for 2 h without any
apoptosis-induction reagent (control) (i), with 40 ng/ml of TNF-α and 100 μg/ml of CHX, (ii) or with 5 μM of CPT (iii). The cell sets were subjected to donor and acceptor emission
dot-plot analysis for untreated cells (upper three panels) and for GFP-Alexa 555-containing cells (middle three panels). Gating for autoﬂuorescent cells were carried out based on the
cell distributions of untreated control cells (the left of upper panels) and the same operations were repeated for all other samples. The elimination of autoﬂuorescent cells was to
remove debris from apoptotic cell blebbing and poor bioprobe uptake cells. These sub cell sets were enclosed with lower acceptor and higher donor emission area (which wemarked
LAHDE in lower three panels) for fractionation of FRET cancelation cells. The gated subpopulations in LAHDE were plotted as functions of the emission ratio to compare FRET
efﬁciencies among three cell sets (the bottom panel). (B) Equivalent experiments to (A) but with RFP–Alexa 647. (C) Approximation of apoptotic induction used in (A) and (B).
Jurkat cells treated in the absence (i) or presence (ii and iii) of the respective reagents for 2 h were further stained with FITC labeled Annexin-V to check the existence of
phosphatidylserine moieties on the cell membranes subjected to staining with Propidium Iodide (PI) and subjected to ﬂow cytometry. Apoptotic cell populations were located in the
Annexin V(+) and PI (−) channels, namely Q4.
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determined to gate cellswithpoor bioprobeuptake andblebbing cells in
theﬁnal stages of apoptosis that jetted out of bioprobes and contributed
autoﬂuorescence in the analysis of thebioprobe-containingcells [17,18].
We also applied this gating process to cells containing the
bioprobes. Sequential expansions of autoﬂuorescent cell populationswere clearly observed for cells under conditions (i) to (iii) in a similar
manner to that shown in the results for nonprocessed cells. Such
subpopulation distributions could arise from differential facilitation of
apoptosis, depending on the stimulation conditions. As in case of
sensing of protease activities, FRET would be suppressed to produce
bioprobes with lower acceptor emission and higher donor emission
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225M. Suzuki et al. / Biochimica et Biophysica Acta 1823 (2012) 215–226(whichwe refer to as LAHDE). As a result, we enclosed the LAHDE area
within the first gated area, i.e. the area corresponding to the cell
population that retained sufﬁcient bioprobe. Cell fractions attributed
to the second gates as LAHDE and consisting of caspase-3-activated
cells, were similarly increased in a manner dependent on the
induction of apoptosis with GFP-based bioprobes (Fig. 4A(g)–(i)).
On the other hand, the LAHDE area for samples treated with the two
reagents for RFP-based bioprobes included a maximum of about 15%
of cells (Fig. 4B(h) and (i)). As we were able to conﬁrm by analysis of
forward and side scatterings that that the eliminated autoﬂuorescent
cells correspond mainly to shrunken cells, a greater reduction in the
size of the CPT-treated samples might be linked to the advanced
occurrence of apoptosis (Fig. 4B(d)–(f)). Nevertheless, nearly con-
stant cell fractions remained in LAHDE while the progress of the
apoptosis was being followed to complete cell death, accompanied by
morphological changes, under these experimental conditions. If
paracrine signaling between apoptotic and nonapoptotic cells to
regulate entry into the apoptotic pathway exists, this distributionmay
not be erroneous.
Finally, we compared the ﬂuorescence properties of cells catego-
rized into LAHDE as a function of their emission ratio on the basis of the
fundamental index for FRET-based bioprobe performance (Fig. 4A(j)
and B(j)). The peak values in histograms for apoptosis-induced cells
were shifted to smaller values in comparison those of nonprocessed
cells, showing that decreases in the emission ratio occur as a result
of cancelation of FRET. The peak originating from the CPT-treated
cell population seemed to be positioned marginally lower than those
of the TNF-α and the CHX treated populations. This suggests that a
steady level of caspase-3 activation is required to execute apoptosis,
whereas different potentials for acceleration of apoptosis occur under
other trigger conditions. These observations show that our FRET-based
bioprobes are capable of sensing caspase-3 activation inside living
cells and of discriminating between various extents of apoptosis arising
from differences in triggering reagents in a high-throughput manner.
Inductions of apoptosis through these treatments were evaluated
by means of annexin V-binding and propidium iodide-staining assays
[19] (Fig. 4C). From the cell distributions shown in Fig. 4C, we
calculated the percentages of apoptotic cells by using the formula
Q4/(Q3+Q4) [19]. The probability of a cell entering an apoptotic
process and remaining there during various stages was calculated to
be 8%, 21%, and 53% for no reagent, TNF-α plus CHX, and CPT,
respectively. This indicated that CPT is more likely to cause apoptosis
than TNF-α plus CHX. However, we were unable to estimate what
proportion of cells remained in the middle stage of apoptosis by using
the stains. Overall, we demonstrated that our combinatorial FRET-based bioprobes are capable of sensing caspase-3 activation inside
living cells and of giving some idea regarding mass reactions to the
induction of apoptosis and of the effect on the extent of occurrence of
apoptosis of changing the triggering reagent(s), in a high-throughput
manner. Although we have already shown by means of microscopy
studies that the bioprobe-containing cells were normal [11], we
additionally examined the scattering proﬁles of Jurkat cells under
various conditions (Supplementary Fig. 1). We were only able to
detect a reduction in scattering of the cells, indicative of a diminution
in size, when the cells were treated with an apoptosis-inducing
reagent. In addition to apoptosis, there are several types of cell death
such as paraptosis, oncosis, and necrosis, which are generally
identiﬁed from the cell phenotypes. These results conﬁrmed that
the introduction of our bioprobe did not have any cytotoxic effect on
the cells.
In summary, we constructed several sets of FRET-based chimeric
bioprobes for one target by simple methods. Although there were
some variations in the sensitivity to caspase-3, we found that all the
bioprobes could be used in quantitative monitoring of the activity of
the enzyme in vitro. By means of ﬂow cytometric studies of the
ﬂuorescence properties of the cells, we veriﬁed that there was
sufﬁcient uptake of the bioprobes into cells and that the cell
distributions were appropriate. We succeeded in estimating the
degree of activation of caspase-3 after stimulation of the apoptotic
pathway in response to triggering reagents by using Jurkat cells
containing various bioprobes. As a result, we believe that our
combinatorial strategy for producing various bioprobes for one target
is a practical and robust method that can be applied in ﬂow cytometry
analysis by using several ﬂuorescent compounds, together with
appropriate adjustments for various instruments [26,27]. In addition,
for the purposes of statistical analyses of living cells, it is probably
necessary to provide supporting data regarding cell–cell communi-
cations, if these occur. We could further improve the intrinsic
sensitivities of our bioprobes by development of the various
components and their linkages, and the overall sensitivities could be
improved by optimization of the amounts and the localization of
bioprobes inside the cells. These improvements might result in a
much more informative sensing system.
We have also established various targeted bioprobes (trypsin,
caspase-9, and cathepsins B, D, and E) consisting of various
ﬂuorescent proteins (BFP, GFP, YFP, or RFP) and dyes for simultaneous
and independent monitoring of several enzymatic reactions. We also
transported several bioprobes together into single cells to show that
ﬂuorescence patterns produced in vitro were comparable with the
results of ﬂuorescence microscopy (unpublished data). We can
226 M. Suzuki et al. / Biochimica et Biophysica Acta 1823 (2012) 215–226therefore use a range of bioprobes together in monitoring of targets
on the basis of their broad ﬂuorescent properties. Once bioprobes are
introduced into cells, they behave like ﬂuorescent proteins expressed
inside the cells or as marked proteins with ﬂuorescent substances in
living cells. The ﬂuorescent indicators can then be used in concert
with our bioprobes, not only to increase ﬂuorescence indices, but also
to achieve greater speciﬁcity in sorting experiments.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.bbamcr.2011.07.006.
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